Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Establishing Clinical Trial Readiness for Children 0-5 Years With Congenital Muscular Dystrophy Secondary to LAMA2 Mutations (READY CMD LAMA2)

NCT06503367 is registered in ClinicalTrials.gov with Nationwide Children's Hospital as lead sponsor.

NCT NCT06503367
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06503367 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Establishing Clinical Trial Readiness for Children 0-5 Years With Congenital Muscular Dystrophy Secondary to LAMA2 Mutations (READY CMD LAMA2)
Lead sponsor
Nationwide Children's Hospital
Phase
Observational
Overall status
Recruiting
Start date
May 12, 2025
Completion date
September 30, 2028
Enrollment
44 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

lama2-md \(merosin deficient congenital muscular dystrophy, mdc1a\)